WHO Guideline: Summary of Recommendations on Pharmaceutical Pricing Policies
How will the new WHO recommendations on pharmaceutical pricing policies affect your organization?
The WHO recently launched a series of recommendations on pharmaceutical pricing policies to help countries make medicines more affordable for the global population and lessen the burden on government budgets.
Alira Health’s Nerea Blanque-Catalina, VP, Market Access & Pricing, and Luis Culla, Associate Director, Global Market Access, dive into these new recommendations and provide advice on how companies can manage the impact of these new guidelines.
For more information and to connect with the team, contact us here.
Listen to our podcast: Alira Health’s Transformation Talks
In this episode we talk about the above-mentioned updated WHO Guideline with our insight industry experts calling from around the globe, Omar Ali, Lecturer Value-Based Pricing and Outcomes Based Innovative Contracting and Former Member Adoption and Impact Panel at NICE, and Oscar Pérez Albet, Chief Business Development and Global Alliances Officer, and our Alira Health hosts Kenny Carberry, Associate Director, Clinical Development, and NereaBlanqué-Catalina, VP, Market Access & Pricing.